冯婷婷职称：副教授
联系电话：**
email：fengtt@mail.ustc.edu.cn
研究方向：1.大数据整合；2.癌症基因组学3.机器学习和生物统计4肿瘤免疫7生物大分子的量子力学与分子动力学计算研究

个人简历科研项目论文专著专利与技术许可荣誉与奖励
本科毕业于安徽师范大学；硕士博士毕业于中国科学技术大学；美国匹兹堡大学医学院从事博士后研究。

1. 主持国家自然科学基金：基于寨卡病毒甲基转移酶蛋白结构筛选和设计高选择性抑制剂的量子力学和分子动力学模拟研究


2. 主持安徽省自然科学基金：乳腺癌上皮间质转化及转移的分子机制研究



1. Feng T(#)，Cao W(#)，Shen W，Zhang L，Gu X，Guo Y，Tsai HI，Liu X，Li J，Zhang J，Li S，Wu F，Liu Y(*)，Arctigenin inhibits STAT3 [and] exhibitsanticancer potential in human triple-negative breast cancer therapy，Oncotarget，2017.1.3，8（1）：329~344


2. Feng, Tingting(#)，Zhang, Yanjun，Ding, Jing-Na，Fan, Song，Han, Ju-Guang(*)，Insights into resistance mechanism of the macrolide biosens[or] protein MphR(A) binding to macrolide antibiotic erythromycin by molecular dynamics simulation.，J Comput Aided Mol Des，2015.12.01，29（12）：1123~1136


3. Fang, Hai-Tong(#)，Zhang, Bo，Pan, Xiao-Fen，Gao, Li，Zhen, Tao，Zhao, Hong-Xia，Ma, Liang，Xie, Jun，Liu, Zi，Yu, Xian-Jun，Cheng, Xin，Feng, Ting-Ting，Zhang, Feng-Xiang，Yang, Yong，Hu, Zhong-Guo，Sheng, Guo-Qing，Chen, Yong-Long，Chen, Sai-Juan，Chen, Zhu，Zhou, Guang-Biao，Bortezomib interferes with C-KIT processing [and] transforms the t(8;21)-generated fusion proteins into tumor-suppressing fragments in leukemia cells. Proc Natl Acad Sci U S A，2012.2.14，109（7）：2521~2526


4. SHAN LI(#)，TING TING FENG(#)，YANG GUO，XIANJUN YU，QIUYUE HUANG，LIANG ZHANG，WEI TANG，YING LIU(*)，Expression of CIP2A in human triple negative breast cancer correlateswith tum[or] survival, invasion, [and] autophagy oncology letters，2016 Dec;12(6):5370-5376


5. Feng, Ting-Ting(#)，Zhang, Yan-Jun，Chen, H，Fan, Song，Han, Ju-Guang，The binding mechanism of a novel nicotinamide isostere inhibiting with TNKSs: a molecular dynamic simulation [and] binding free energy calculation.，J Biomol Struct Dyn，2016.01.01，34（3）：517~528


6. Zhang, Caiying(#)，Feng, Tingting，Cheng, Jinbo，Li, Yajuan，Yin, Xueying，Zeng, Weihong，Jin, Xiangyu，Li, Yuelong，Guo, Feng，Jin, Tengchuan(*)，Structure of the NS5 methyltransferase from Zika virus [and] implications in inhibit[or] design.，Biochem Biophys Res Commun，2016.11.17


7. Hu, Zheng(#)，Pan, Xiao-Fen，Wu, Fu-Qun，Ma, Li-Yuan，Liu, Da-Peng，Liu, Ying，Feng, Ting-Ting，Meng, Fan-Yi，Liu, Xiao-Li，Jiang, Qian-Li，Chen, Xiao-Qin，Liu, Jing-Lei，Liu, Ping，Chen, Zhu，Chen, Sai-Juan，Zhou, Guang-Biao，Synergy between proteasome inhibitors [and] imatinib mesylate in chronic myeloid leukemia.，PLoS One，2009.7.16，4（7）：e6257~e6257


8. Zhang, Yan-Jun(#)，Ding, Jing-Na，Feng, Ting-Ting，Han, Ju-Guang，Exploring interaction mechanisms of the inhibit[or] binding to the VP35 IID region of Ebola virus by all atom molecular dynamics simulation method.，Proteins，2015.12.01，83（12）：2263~2278


9. Chen, Hang(#)，Zhang, Ying，Ye, Chun，Feng, Ting T，Han, Ju G，Insight into the binding modes [and] inhibition mechanisms of adamantyl-based 1,3-disubstituted urea inhibitors in the active site of the human soluble epoxide hydrolase.，J Biomol Struct Dyn，2014.01.01，32（8）：1231~1247



国家专利：一种蛋白磷酸酶2A癌性抑制因子抑制剂及其制备方法。

荣誉与奖励建设中...